- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06631027
Dietary Adherence and Cognitive Function in Older Adults
October 4, 2024 updated by: Emine Elibol, Ankara Yildirim Beyazıt University
The Relationship Between Adherence to Mediterranean, DASH and MIND Diets and Cognitive Function in Older Adults
This study aimed to evaluate the relationship between adherence to the Mediterranean, DASH, and MIND diets and cognitive function in elderly individuals.
Data were collected from 1,027 participants aged 65 and older, using dietary assessment tools and the Standardized Mini Mental Test (SMMT), and were analyzed with SPSS 26.
Study Overview
Status
Completed
Detailed Description
A total of 1027 elderly individuals aged 65 years and over were included in the study.
Demographic questionnaire and Mediterranean diet adherence scale were administered to the individuals.
Adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet was scored and food consumption was recorded for adherence to the Dietary Approaches to Stop Hypertension (DASH) diet.
Standardised mini mental test (SMMT) was used to assess mental status.
Data were analysed with SPSS 26 software.
Study Type
Observational
Enrollment (Actual)
1027
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06760
- Ankara Yıldırım Beyazıt University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Community sample in Ankara, Turkey
Description
Inclusion Criteria:
1. Individuals aged 65 years and older.
Exclusion Criteria:
1. Individuals diagnosed with psychiatric or neurological diseases (e.g., dementia, Alzheimer's disease).
3. Individuals with alcohol or drug addiction. 4. Illiterate individuals.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Elderly Participants (65 years and older)
This study focuses on a cohort of 1,027 elderly participants aged 65 years and older.
The participants were assessed for their adherence to the Mediterranean, DASH, and MIND diets through a demographic questionnaire and dietary adherence scales.
Cognitive function was evaluated using the Standardized Mini-Mental Test (SMMT).
The study aims to explore the relationship between dietary patterns and cognitive health in this population.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive Function Assessment
Time Frame: Basaline
|
The primary outcome measure is the cognitive function of elderly individuals assessed using the Standardized Mini-Mental Test.
The total Standardized Mini-Mental Test score is analyzed to evaluate the relationship between dietary adherence and cognitive function.The test is scored according to the answers given to each question and evaluated over 30 points in total.
On a 30-point scale, a score of 24 and above indicates normal cognition, while a score below 24 indicates impaired cognitive function.
|
Basaline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sociodemographic characteristics
Time Frame: basaline
|
number and percentage
|
basaline
|
|
Mediterranean Diet Adherence Scale
Time Frame: Basaline
|
Adherence to the Mediterranean Diet will be assessed using the Mediterranean Diet Adherence Scale.
Scores will range from 0 to 14, with scores below 7 indicating non-compliance, 7-8 indicating acceptable compliance, and 9 and above indicating strict adherence to the Mediterranean diet.
|
Basaline
|
|
Compliance with the Dietary Approaches to Stop Hypertension diet
Time Frame: Basaline
|
Compliance with the Dietary Approaches to Stop Hypertension diet will be assessed using a 24-hour recall method to evaluate dietary intake.
Scores range from 0 to 9, with scores of 4.5 or above indicating compliance with the DASH diet.
This assessment will be used to explore the relationship between DASH diet adherence and cognitive function in elderly individuals.
|
Basaline
|
|
Compliance with the Mediterranean-DASH Intervention for Neurodegenerative Delay diet
Time Frame: Basaline
|
Compliance with the Mediterranean-DASH Intervention for Neurodegenerative Delay diet will be assessed by evaluating the frequency and portion sizes of key dietary components, Higher scores indicate greater adherence to the MIND diet.
In this study, a median score of 7.5 will be used to categorize participants into two groups: those with a low level of adherence (score ≤7.5) and those with a high level of adherence (score >7.5).
|
Basaline
|
|
Body Mass Index (BMI)
Time Frame: Basaline
|
Kilograms per square meter (kg/m2)
|
Basaline
|
|
Body weight
Time Frame: Basaline
|
Body weight in kg
|
Basaline
|
|
Height
Time Frame: Basaline
|
Height in cm
|
Basaline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2024
Primary Completion (Actual)
June 15, 2024
Study Completion (Actual)
August 1, 2024
Study Registration Dates
First Submitted
September 27, 2024
First Submitted That Met QC Criteria
October 4, 2024
First Posted (Actual)
October 8, 2024
Study Record Updates
Last Update Posted (Actual)
October 8, 2024
Last Update Submitted That Met QC Criteria
October 4, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AYBUELİBOL001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.